Saturday, November 23, 2024

2023 Lancet Report on health and climate change: a critical call for comprehensive global...

In-depth analysis of the escalating health crisis due to climate change and the imperative for systemic global climate action.

Newborns torn from mothers: South Carolina’s harsh crackdown on drug use during pregnancy

South Carolina leads the charge in prosecuting pregnant women for substance abuse.

Chemical catastrophe: daily disasters spotlight America’s toxic time bomb

U.S. struggles with daily hazardous chemical incidents, underlining systemic safety lapses.

Fossil fuels: the hidden ingredient in our food chain

Unveiling the entwined destiny of our food systems and climate crisis

Methane emissions from food waste alarmingly accelerate climate crisis

As EPA reports highlight the staggering methane emissions from food waste, the U.S. grapples with an overlooked environmental hazard.

Sanders demands probe of push to give company patent for public-funded cancer treatment

Sanders demanded a probe of the National Institutes of Health (NIH) patent proposal in a letter to Christi Grimm, inspector general of the U.S. Department of Health and Human Services.

‘For shame’: Pfizer to charge $1,390 for lifesaving Covid drug that costs Just $13

"Pfizer treats Paxlovid like a Prada handbag; a luxury for the few rather than a treatment for the many," said one consumer advocate.

Offering treatment to drug users instead of arresting them reduces crime and addiction –...

Treatment programs rather than incarceration are far more effective for drug-related offenses.

Medicare Advantage overbills taxpayers by $140 billion a year—enough to wipe out Medicare premiums

"Medicare Advantage is just another example of the endless greed of the insurance industry poisoning American healthcare," says a new report from Physicians for a National Health Program.

How a big pharma company stalled a potentially lifesaving vaccine in pursuit of bigger...

A vaccine against tuberculosis, the world’s deadliest infectious disease, slowed after its corporate owner focused on more profitable vaccines.